A key translational research initiative for Dean and Professor Steve Swanson is realized this July as the Medicinal Chemistry Center (MCC) of the UW-Madison School of Pharmacy is launched.
Pharmaceutical Sciences
Tang awarded funding from WARF’s Accelerator Program
Weiping Tang, associate professor in the Pharmaceutical Sciences Division, will receive an award from the Wisconsin Alumni Research Foundation (WARF) Accelerator Program that supports his project titled “Small Molecule Inhibitors of PCSK9 Secretion – Phase …
deVilliers paper selected “Top Pick”
Melgardt de Villiers, professor (CHS) in the Pharmaceutical Sciences Division and Associate Dean for Academic Affairs, is among the authors of a paper selected Editor’s Pick for the May issue of Expert Opinion of Drug …
Spring 2015 Doctor of Philosophy in Pharmaceutical Sciences Graduates
Congratulations to the following students who successfully defended their dissertations: Yan Wang, under the supervision of Dr. May Xiong: Development of Nanotechnologies for Cancer and Iron Chelation Therapy. San Zeng, under the supervision of Dr. …
Kwan receives grant to study biofilm inhibitors
Jason Kwan, assistant professor in the Pharmaceutical Sciences Division, has been awarded a research starter grant from the American Society of Pharmacognosy. The grant will support Kwan’s research in the investigation of novel biofilm inhibitors …
Winston-McPherson named 2015 UNCF-Merck Graduate Science Research Fellow
Gabrielle Winston-McPherson, SciMed GRS Fellow and Research Assistant in the lab of Weiping Tang, Pharmaceutical Sciences Division, has been selected to participate in the United Negro College Fund, Inc. (UNCF) and the Merck Company Foundation …
Pharm Sci and SAS announce incoming graduate students
More than 180 individuals applied to the Pharmaceutical Sciences Doctoral Program for fall 2015 admission. Twenty-two were offered admission, and the school will welcome the following eight new graduate students this September: Mark Cadena, a …
Drug developed by Kwon receives granted orphan designation by FDA
Co-D Therapeutics, Inc., a pre-clinical stage pharmaceutical company developing agents for the treatment of cancer, was granted orphan designation for Triolimus for the treatment of Angiosarcoma. Triolimus technology was developed by Glen Kwon, professor in …
Zhang is Journal of Polymer Science poster prize winner
Wei Zhang, graduate student in the lab of Lian Yu, professor in the Pharmaceutical Sciences Division, was one of three outstanding young polymer scientists awarded the 2015 Journal of Polymer Science poster prize for the …
Kwon named regional editor
Glen Kwon, professor in the Pharmaceutical Sciences Division, was selected to be a Regional Editor for the journal Pharmaceutical Nanotechnology. Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide …